Pathfinder Cell Therapy Stock Buy Hold or Sell Recommendation
| PFND Stock | USD 0.0001 0.00 0.00% |
Given the investment horizon of 90 days and complete risk avoidance on your part, our recommendation regarding Pathfinder Cell Therapy is 'Strong Sell'. Macroaxis provides Pathfinder Cell buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding PFND positions.
Check out Pathfinder Cell Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Pathfinder and provide practical buy, sell, or hold advice based on investors' constraints. Pathfinder Cell Therapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Pathfinder |
Execute Pathfinder Cell Buy or Sell Advice
The Pathfinder recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Pathfinder Cell Therapy. Macroaxis does not own or have any residual interests in Pathfinder Cell Therapy or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Pathfinder Cell's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Pathfinder Cell Trading Alerts and Improvement Suggestions
| Pathfinder Cell generated a negative expected return over the last 90 days | |
| Pathfinder Cell has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (1.39 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pathfinder Cell Therapy currently holds about 4 K in cash with (963 K) of positive cash flow from operations. |
Pathfinder Cell Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pathfinder Cell or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pathfinder Cell's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pathfinder pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Pathfinder Cell Volatility Alert
At this time Pathfinder Cell Therapy exhibits very low volatility. Pathfinder Cell Therapy appears to be a penny stock. Although Pathfinder Cell Therapy may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Pathfinder Cell Therapy or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Pathfinder instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Pathfinder Cell Fundamentals Vs Peers
Comparing Pathfinder Cell's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Pathfinder Cell's direct or indirect competition across all of the common fundamentals between Pathfinder Cell and the related equities. This way, we can detect undervalued stocks with similar characteristics as Pathfinder Cell or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Pathfinder Cell's fundamental indicators could also be used in its relative valuation, which is a method of valuing Pathfinder Cell by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Pathfinder Cell to competition |
| Fundamentals | Pathfinder Cell | Peer Average |
| Return On Asset | -8.89 | -0.14 |
| Current Valuation | 7.41 M | 16.62 B |
| Shares Outstanding | 667.16 M | 571.82 M |
| EBITDA | (1.67 M) | 3.9 B |
| Net Income | (1.39 M) | 570.98 M |
| Cash And Equivalents | 4 K | 2.7 B |
| Total Debt | 5.41 M | 5.32 B |
| Book Value Per Share | (0.01) X | 1.93 K |
| Cash Flow From Operations | (963 K) | 971.22 M |
| Number Of Employees | 1 | 18.84 K |
| Beta | 0.14 | -0.15 |
| Market Capitalization | 2 M | 19.03 B |
| Total Asset | 106 K | 29.47 B |
| Retained Earnings | (19.23 M) | 9.33 B |
| Working Capital | (6.76 M) | 1.48 B |
| Current Asset | 9 K | 9.34 B |
| Current Liabilities | 6.77 M | 7.9 B |
| Net Asset | 106 K |
Pathfinder Cell Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Pathfinder . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
About Pathfinder Cell Buy or Sell Advice
When is the right time to buy or sell Pathfinder Cell Therapy? Buying financial instruments such as Pathfinder Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Pathfinder Cell in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Macroaxis Picks Thematic Idea Now
Macroaxis Picks
Daily selected watch list of stocks of large companies handpicked by Macroaxis Team based on their diversification potential. The Macroaxis Picks theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Picks Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Pathfinder Pink Sheet
Pathfinder Cell financial ratios help investors to determine whether Pathfinder Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pathfinder with respect to the benefits of owning Pathfinder Cell security.